Analogic Corporation (ALOG) Raised to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Analogic Corporation (NASDAQ:ALOG) from a hold rating to a buy rating in a research note published on Tuesday morning. They currently have $93.00 target price on the medical research company’s stock.

According to Zacks, “Analogic Corporation designs, manufactures, and sells medical imaging, ultrasound, and security systems and subsystems to original equipment manufacturers (OEMs) and end users primarily for the healthcare and airport security markets. Its operates in three segments, Medical Imaging, Ultrasound, and Security and Detection. The Medical Imaging segment provides medical imaging systems and subsystems, including computed tomography (CT) detector systems, data acquisition systems, data management systems, and integrated CT gantries, and digital mammography products consisting of detector plates, as well as motion control devices for use in computer-controlled automation systems. The Ultrasound segment designs and manufactures medical ultrasound systems under the BK Ultrasound brand for use in urology, surgery, point-of-care, anesthesia, and general imaging applications. The Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications. “

Separately, Jefferies Group LLC assumed coverage on shares of Analogic Corporation in a research report on Wednesday, August 9th. They issued a hold rating and a $75.00 price objective for the company. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of $85.25.

Analogic Corporation (NASDAQ ALOG) traded down 0.67% during mid-day trading on Tuesday, reaching $81.70. 12,040 shares of the company’s stock were exchanged. The stock’s market cap is $1.02 billion. Analogic Corporation has a 52-week low of $66.00 and a 52-week high of $95.85. The company has a 50-day moving average of $77.97 and a 200-day moving average of $73.12.

WARNING: This piece of content was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://sportsperspectives.com/2017/10/13/analogic-corporation-alog-raised-to-buy-at-zacks-investment-research.html.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a $0.10 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.49%. Analogic Corporation’s dividend payout ratio (DPR) is currently -6.70%.

Hedge funds have recently added to or reduced their stakes in the company. SG Americas Securities LLC bought a new position in shares of Analogic Corporation in the first quarter valued at approximately $101,000. US Bancorp DE boosted its position in shares of Analogic Corporation by 59.0% in the first quarter. US Bancorp DE now owns 1,635 shares of the medical research company’s stock valued at $124,000 after acquiring an additional 607 shares during the period. Flinton Capital Management LLC boosted its position in shares of Analogic Corporation by 100.0% in the second quarter. Flinton Capital Management LLC now owns 1,768 shares of the medical research company’s stock valued at $129,000 after acquiring an additional 884 shares during the period. State of Alaska Department of Revenue boosted its position in shares of Analogic Corporation by 78.9% in the second quarter. State of Alaska Department of Revenue now owns 2,469 shares of the medical research company’s stock valued at $179,000 after acquiring an additional 1,089 shares during the period. Finally, Dubuque Bank & Trust Co. boosted its position in shares of Analogic Corporation by 8.8% in the second quarter. Dubuque Bank & Trust Co. now owns 2,651 shares of the medical research company’s stock valued at $193,000 after acquiring an additional 215 shares during the period. Institutional investors own 99.06% of the company’s stock.

Analogic Corporation Company Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Get a free copy of the Zacks research report on Analogic Corporation (ALOG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply